Dr. Kesler is a cognitive neuroscientist with specific expertise in neuroimaging, neuropsychology, biostatistics, machine learning, and computer programming. Her research program focuses on the neural mechanisms of cancer-related cognitive neurotoxicities including both clinical and preclinical studies that involve translational approaches for measuring the functional and structural connectome in both humans and rodents using neuroimaging. The overarching goals of her work concern the neurobiologic subtyping of chemotherapy-related cognitive impairments as well as neuroimaging-based prediction of cognitive-behavioral outcomes, survival and treatment response in patients with cancer across the lifespan.
Shelli Kesler
